Paul J. Lytle
CIK: 0001244110
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACTUATE THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Apr 1, 2026ACTU
ACTUATE THERAPEUTICS, INC.
Award(A)DirectEmployee Stock Option (right to buy)
105K shares- - Apr 1, 2025ACTU
ACTUATE THERAPEUTICS, INC.
Award(A)DirectEmployee Stock Option (right to buy)
49.4K shares- - Apr 1, 2025ACTU
ACTUATE THERAPEUTICS, INC.
Award(A)DirectEmployee Stock Option (right to buy)
41.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 1, 2026 | ACTU ACTUATE THERAPEUTICS, INC. | Award(A) Employee Stock Option (right to buy) | 105,000 | - | - | Direct |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | Award(A) Employee Stock Option (right to buy) | 49,394 | - | - | Direct |
| Apr 1, 2025 | ACTU ACTUATE THERAPEUTICS, INC. | Award(A) Employee Stock Option (right to buy) | 41,899 | - | - | Direct |
1-3 of 3 transactions
About LYTLE PAUL J
LYTLE PAUL J (SEC CIK 0001244110) files insider reports with the SEC as Chief Financial Officer of ACTUATE THERAPEUTICS, INC. (ACTU).
Signal8 holds 2 ownership filings by LYTLE PAUL J, all Form 4s, filed between Apr 2, 2025 and Apr 1, 2026. Those filings report 3 transactions, from Apr 1, 2025 to Apr 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LYTLE PAUL J's filings is in FORT WORTH, TX.
Recent filings by LYTLE PAUL J
Other insiders filing for ACTUATE THERAPEUTICS, INC. (ACTU)
- THOMSON TODD S, Director
- BIOS Fund III, LP, Director
- BIOS Fund I, LP, Director
- SCHMITT DANIEL M, President, CEO and Director
- Zabrowski Dan, Director
- Sawhney Roger, Director